Dara-PD in the Treatment of Patients With First Relapse of Multiple Myeloma
Clinical trial NCT06252792 · RECRUITING
Trial details
- NCT number
- NCT06252792
- Sponsor
- FengYan Jin
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2023-06-15
- Primary completion
- 2026-06-15
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.